Dr Kluger on the FDA Approval of Lifileucel in Advanced Melanoma

Harriet Kluger, MD, discusses the FDA approval of the tumor infiltrating lymphocyte therapy lifileucel for patients with advanced melanoma.

Related Keywords

Harriet Kluger ,Faculty Development ,Translational Research ,Yale Cancer Center ,Division Of Skin ,Kate Cushing Professor ,Skin Cancer ,Internal Medicine ,Kidney Cancer ,Medical Oncology ,D ,Fda Approval Of Lifileucel ,Patients With Advanced Melanoma ,